(BOYSON): MOLECULAR DETERMINANTS OF NKT CELL ACTIVATION BY CD1D AND ITS LIGANDS

(Boyson):CD1D 及其配体激活 NKT 细胞的分子决定因素

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ***Please note: Dr. Boyson "graduated" off the COBRE as of 10/1/2008. He now serves as a mentor for Dr. Jason Botten. Invariant natural killer T (iNKT) cells comprise a novel subset of T cells that has a profound effect on infectious disease, autoimmunity, tolerance induction, and tumor immunology. NKT cells can be activated through recognition of microorganism-derived glycolipids presented by CD1d (direct pathway), or through IL-12 and IL-18 produced by antigen presenting cells activated by TLR ligands (indirect pathway). Upon activation, NKT cells rapidly secrete large amounts of a wide variety of cytokines and activate other leukocyte subsets such as dendritic cells, macrophages, B cells, and natural killer cells. Given their relatively high frequency in the gut, liver, and lung, these observations suggest that NKT cells may play a role in early events of a developing immune response. During this funding period, we have focused our attention on investigation of genetic determinants of NKT cell function. We have published the observation that there is widespread variation in NKT cell number and function among different genetic backgrounds. These strain-dependent differences are correlated with significant physiological effects such as shared susceptibility to aGalCer-induced airway hyperreactivity (a cardinal feature of asthma), aGalCer-induced liver injury, and aGalCer-induced pregnancy loss. We have now extended this work by investigating the significance of strain-dependent variation in NKT cell number and function. We have found that strains exhibiting low NKT cell number and function, such as 129S1/SvImJ, respond poorly in vivo to LPS. We have also found that liver NKT cell number is under strictly controlled by the SLAM/CD2 locus on chromosome 1 which possesses numerous polymorphisms between strains. Most interesting, we have found using a congenic strain where the 129S1/SvImJ SLAM/CD2 locus was introgressed onto the C57BL/6J background that, in addition to controlling liver NKT cell number, the SLAM/CD2 locus controls the in vivo response to LPS. Taken together, our data suggest that SLAM-dependent control of NKT cell number modulates the in vivo response to TLR ligands. We are currently preparing a manuscript for submission. Publications 2008: Rymarchyk, S.L., H. Lowenstein, J. Mayette, S.R. Foster, D. Damby, I.W. Howe, I. Aktan, R.E. Meyer, M.E. Poynter, and J.E. Boyson. 2008. Widespread natural variation in NKT cell number and function. Immunology 125:331-343. Exley, M.A., R. Hou, A. Shaulov, E. Tonti, P. Dellabona, G. Casorati, O. Akbari, H.O. Akman, E.A. Greenfield, J.E. Gumperz, J.E. Boyson, S.P. Balk, and S.B. Wilson. 2008. Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop. European Journal of Immunology 38(6):1756-1766. J.E. Boyson, I. Aktan, D. Barkhuff, and A. Chant. NKT cells at the maternal-fetal interface. 2008. Immunological Investigations 37:565-582. Olson Jr., C.M., T.C. Bates, H. Izadi, J.D. Radolf, S.A. Huber, J.E. Boyson, and J. Anguita. 2009. Local regulation of interferon gamma by invariant natural killer T cells modulates acute lyme carditis. Journal of Immunology 182(6): p. 3728-3734. Paveglio, S, J. Allard, S. Foster, J. Ather, M. Bevelander, J. Mayette, L. Whittaker, J.E. Boyson, and M.E. Poynter. Overexpression of IDO within mouse airway epithelial cells mitigates CD4+ T-cell activities during Aspergillus fumigatus antigen exposure (submitted). Mentoring Summaries: Elizabeth A. Bonney, M.D. As a member of the COBRE for the Vermont Center for Immunology and Infectious disease I have mentoring relationships with several levels of trainees within the COBRE, including graduate students and post doctoral fellows. I served as the mentor for Jon Boyson, who, as of June 2008 "graduated " to the level of Senior Faculty, and who currently mentors Jason Botten. Jon and I continue to collaborate on issues related to biology of abnormal pregnancy. I continue to offer support in terms of delineation and achievement of long-term career goals. We continue to meet approximately once every two months. Jason and I collaborate on using a mouse model better understand the immunobiology of infection with Lymphocytic choriomeningitis virus, particularly as it relates to tissue-specific immunity.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHAN E BOYSON其他文献

JONATHAN E BOYSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHAN E BOYSON', 18)}}的其他基金

Development and function of innate-like gamma delta T cells
先天性γδT细胞的发育和功能
  • 批准号:
    10624417
  • 财政年份:
    2022
  • 资助金额:
    $ 4.15万
  • 项目类别:
Development and function of innate-like gamma delta T cells
先天性γδT细胞的发育和功能
  • 批准号:
    10527432
  • 财政年份:
    2022
  • 资助金额:
    $ 4.15万
  • 项目类别:
Defining the SAP-dependent and SAP-independent gamma delta TCR repertoire
定义 SAP 相关和 SAP 独立的 gamma delta TCR 指令集
  • 批准号:
    10170255
  • 财政年份:
    2020
  • 资助金额:
    $ 4.15万
  • 项目类别:
Defining the SAP-dependent and SAP-independent gamma delta TCR repertoire
定义 SAP 相关和 SAP 独立的 gamma delta TCR 指令集
  • 批准号:
    10043222
  • 财政年份:
    2020
  • 资助金额:
    $ 4.15万
  • 项目类别:
Upgrade of a FACS Aria Cell Sorter
FACS Aria 细胞分选仪的升级
  • 批准号:
    8826515
  • 财政年份:
    2015
  • 资助金额:
    $ 4.15万
  • 项目类别:
VERMONT COBRE (BOYSON) PROJECT 4: GENETIC DETERMINANTS OF NKT CELL FUNCTION
佛蒙特州 COBRE (Boyson) 项目 4:NKT 细胞功能的遗传决定因素
  • 批准号:
    8360771
  • 财政年份:
    2011
  • 资助金额:
    $ 4.15万
  • 项目类别:
VERMONT COBRE (BOYSON) PROJECT 4: GENETIC DETERMINANTS OF NKT CELL FUNCTION
佛蒙特州 COBRE (Boyson) 项目 4:NKT 细胞功能的遗传决定因素
  • 批准号:
    8167730
  • 财政年份:
    2010
  • 资助金额:
    $ 4.15万
  • 项目类别:
VERMONT COBRE: PROJECT 1: INKT CELL ACTIVATION BY CD ID & ITS LIGANDS
佛蒙特州 COBRE:项目 1:通过 CD ID 激活 INKT 细胞
  • 批准号:
    7720915
  • 财政年份:
    2008
  • 资助金额:
    $ 4.15万
  • 项目类别:
CD1D-Restricted T cells and Pregnancy Loss
CD1D 限制性 T 细胞与流产
  • 批准号:
    7263318
  • 财政年份:
    2007
  • 资助金额:
    $ 4.15万
  • 项目类别:
CD1D-Restricted T cells and Pregnancy Loss
CD1D 限制性 T 细胞与流产
  • 批准号:
    7570046
  • 财政年份:
    2007
  • 资助金额:
    $ 4.15万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 4.15万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了